Related references
Note: Only part of the references are listed.Amelioration of established murine collagen-induced arthritis with anti-IL-1 treatment
W. B. BERG et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Translational Mini-Review Series on Th17 Cells: Are T helper 17 cells really pathogenic in autoimmunity?
M. I. Koenders et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Myeloid-related proteins S100A8/S100A9 regulate joint inflammation and cartilage destruction during antigen-induced arthritis
P. L. E. M. van Lent et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Stimulation of Chondrocyte-Mediated Cartilage Destruction by S100A8 in Experimental Murine Arthritis
P. L. E. M. van Lent et al.
ARTHRITIS AND RHEUMATISM (2008)
Interleukin-1 Drives Pathogenic Th17 Cells During Spontaneous Arthritis in Interleukin-1 Receptor Antagonist-Deficient Mice
Marije I. Koenders et al.
ARTHRITIS AND RHEUMATISM (2008)
Structure-function relationships in the IL-17 receptor: Implications for signal transduction and therapy
Fang Shen et al.
CYTOKINE (2008)
Blockade of tumor necrosis factor in collagen-induced arthritis reveals a novel immunoregulatory pathway for Th1 and Th17 cells
Clare A. Notley et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
IL-17 enhances chemokine gene expression through mRNA stabilization
Justin Hartupee et al.
JOURNAL OF IMMUNOLOGY (2007)
Interleukin-17 acts independently of TNF-α under arthritic conditions
Marije I. Koenders et al.
JOURNAL OF IMMUNOLOGY (2006)
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
H Park et al.
NATURE IMMUNOLOGY (2005)
Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages
LE Harrington et al.
NATURE IMMUNOLOGY (2005)
Interleukin-17 receptor deficiency results in impaired synovial expression of interleukin-1 and matrix metalloproteinases 3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall-induced arthritis
MI Koenders et al.
ARTHRITIS AND RHEUMATISM (2005)
Blocking of interleukin-17 during reactivation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and interleukin-1
MI Koenders et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Induction of Cartilage Damage by Overexpression of T Cell Interleukin-17A in Experimental Arthritis in Mice Deficient in Interleukin-1
Marije I. Koenders et al.
ARTHRITIS AND RHEUMATISM (2005)
Anti-TNF therapy: Where have we got to in 2005?
M Feldmann et al.
JOURNAL OF AUTOIMMUNITY (2005)
The role of T cell interleukin-17 in conducting destructive arthritis: lessons from animal models
E Lubberts et al.
ARTHRITIS RESEARCH & THERAPY (2005)
Requirement of IL-17 receptor signaling in radiation-resistant cells in the joint for full progression of destructive synovitis
E Lubberts et al.
JOURNAL OF IMMUNOLOGY (2005)
Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion
E Lubberts et al.
ARTHRITIS AND RHEUMATISM (2004)
Functional cooperation between interleukin-17 and tumor necrosis factor-α is mediated by CCAAT/enhancer-binding protein family members
MJ Ruddy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The impact of new biologicals in the treatment of rheumatoid arthritis
A. L. Weaver
RHEUMATOLOGY (2004)
IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist
S Nakae et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Interleukin-17 in rheumatoid arthritis - If T cells were to contribute to inflammation and destruction through synergy
P Miossec
ARTHRITIS AND RHEUMATISM (2003)
IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-κB ligand/osteoprotegerin balance
E Lubberts et al.
JOURNAL OF IMMUNOLOGY (2003)
Gene expression induced by interleukin-17 in fibroblast-like synoviocytes of patients with rheumatoid arthritis: upregulation of hyaluronan-binding protein TSG-6
A Kehlen et al.
ARTHRITIS RESEARCH & THERAPY (2003)
Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice
S Nakae et al.
JOURNAL OF IMMUNOLOGY (2003)
Interleukin 17 synergises with tumour necrosis factor α to induce cartilage destruction in vitro
RL van Bezooijen et al.
ANNALS OF THE RHEUMATIC DISEASES (2002)
Addition of interleukin 1 (IL1) and IL17 soluble receptors to a tumour necrosis factor α soluble receptor more effectively reduces the production of IL6 and macrophage inhibitory protein-3α and increases that of collagen in an in vitro model of rheumatoid synoviocyte activation
G Chevrel et al.
ANNALS OF THE RHEUMATIC DISEASES (2002)
Expression, modulation and signalling of IL-17 receptor in fibroblast-like synoviocytes of patients with rheumatoid arthritis
A Kehlen et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2002)
Enhancing effect of IL-1, IL-17, and TNF-α on macrophage inflammatory protein-3α production in rheumatoid arthritis:: Regulation by soluble receptors and Th2 cytokines
M Chabaud et al.
JOURNAL OF IMMUNOLOGY (2001)
IL-1-independent role of IL-17 in synovial inflammation and joint destruction during collagen-induced arthritis
E Lubberts et al.
JOURNAL OF IMMUNOLOGY (2001)
Anti-tumor necrosis factor therapies
PC Taylor
CURRENT OPINION IN RHEUMATOLOGY (2001)
IL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritis
M Chabaud et al.
ARTHRITIS RESEARCH (2001)
High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism
N Ziolkowska et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
